.svg){kind=small}
Richmond Pharmacology will be attending the 5th Annual Cardiovascular Risk Assessment Summit taking place 26th to 27th January 2011 in Alexandria, Virginia.
11
January 2011
Announcement on Japanese Representation Business Agreement between Richmond Pharmacology and ACRONET Corporation.
15
November 2010
Richmond Pharmacology will be attending the 4th DIA European Cardiac Safety Conference taking place later this month in Nice from 25th to 26th October 2010.
15
October 2010
-min.jpg)
.jpg)
Latest news
Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme
February 17, 2025
We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...
Read moreTrial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join
February 10, 2025
The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...
Read moreEvents
CRISPR Medicine 2025: Unlocking Gene-Editing Potential
April 7–11
Exploring advancements shaping the future of healthcare.
View event
